Metraipolis › archive › dc_e8ddabd8697e

Credibility assessment of in silico clinical trials for medical devices — Europe PMC PMID:39116026

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39116026
DOI
10.1371/journal.pcbi.1012289
License (as archived)
CC0-1.0
Archived
2026-10-06T16:54:36.805Z
SHA-256 of the archived text
bab2b05df50ef873741a34f569850440e779d27fd569e3ed11f0c49b60e6d1ab
Stable URL of this page
https://metraipolis.com/documento/dc_e8ddabd8697e

How to cite

Credibility assessment of in silico clinical trials for medical devices — Europe PMC PMID:39116026 — Europe PMC (en), https://europepmc.org/article/MED/39116026 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_e8ddabd8697e (Metraipolis archive dc_e8ddabd8697e, sha256 bab2b05df50ef873741a34f569850440e779d27fd569e3ed11f0c49b60e6d1ab)
BibTeX
@misc{dce8ddabd8697e,
  title = {Credibility assessment of in silico clinical trials for medical devices — Europe PMC PMID:39116026},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39116026},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_e8ddabd8697e; sha256 bab2b05df50ef873741a34f569850440e779d27fd569e3ed11f0c49b60e6d1ab},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/39116026. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

In silico clinical trials (ISCTs) are an emerging method in modeling and simulation where medical interventions are evaluated using computational models of patients. ISCTs have the potential to provide cost-effective, time-efficient, and ethically favorable alternatives for evaluating the safety and effectiveness of medical devices. However, ensuring the credibility of ISCT results is a significant challenge. This paper aims to identify unique considerations for assessing the credibility of ISCTs and proposes an ISCT credibility assessment workflow based on recently published model assessment frameworks. First, we review various ISCTs described in the literature, carefully selected to showcase the range of methodological options available. These studies cover a wide variety of devices, reasons for conducting ISCTs, patient model generation approaches including subject-specific versus 'synthetic' virtual patients, complexity levels of devices and patient models, incorporation of clinician or clinical outcome models, and methods for integrating ISCT results with real-world clinical trials. We next discuss how verification, validation, and uncertainty quantification apply to ISCTs, considering the range of ISCT approaches identified. Based on our analysis, we then present a hierarchical workflow for assessing ISCT credibility, using a general credibility assessment framework recently published by the FDA's Center for Devices and Radiological Health. Overall, this work aims to promote standardization in ISCTs and contribute to the wider adoption and acceptance of ISCTs as a reliable tool for evaluating medical devices.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS computational biology, 2024 (prima pubblicazione 2024-08-08).
Identificativi: PMID 39116026 · PMCID PMC11309390 · DOI 10.1371/journal.pcbi.1012289.
Descrittori MeSH principali: Equipment and Supplies; Computer Simulation; Clinical Trials as Topic.
Pagina: https://europepmc.org/article/MED/39116026 — https://doi.org/10.1371/journal.pcbi.1012289. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T15:19:26.732Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.